Fluoxetine Treatment Induces Seizure Behavior and Premature Death in APPswe/PS1dE9 Mice

Annerieke S. R. Sierksma, Laurence de Nijs, Govert Hoogland, Tim Vanmierlo, Fred W. van Leeuwen, Bart P. F. Rutten, Harry W. M. Steinbusch, Jos Prickaerts, Daniel L. A. van den Hove*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Web of Science)


Treatment of Alzheimer's disease (AD) patients with the antidepressant fluoxetine is known to improve memory and cognitive function. However, the mechanisms underlying these effects are largely unknown. To unravel these mechanisms, we aimed to treat APPswe/PS1dE9 mice with fluoxetine. Unexpectedly, with time, an increased number of animals displayed seizure behavior and died. Although spontaneous behavioral seizures have been reported previously in this mouse model, the observation of seizures and death consequential to fluoxetine treatment is new. Our results warrant further research on the underlying mechanisms as this may refine the treatment of AD patients.
Original languageEnglish
Pages (from-to)677-682
JournalJournal of Alzheimer's Disease
Issue number3
Publication statusPublished - 2016


  • Alzheimer's disease
  • APPswe/PS1dE9
  • epilepsy
  • fluoxetine
  • premature death
  • seizure

Cite this